Brief: Asit Biotech presents ASIT+ benefits in treating grass pollen rhinitis

European Medical Solutions SA

06/12/2016 07:10

Dec 6(Reuters) - Asit Biotech SA  ASIT.BR : 
    * Reported on Monday ASIT+ technology's benefits in treating 
grass pollen rhinitis presented during a scientific session at 
Medical Research Council & Asthma UK Centre in London 
    * gp-ASIT+ is the Company`s most advanced drug candidate 
    * Its clinical efficacy is being investigated in a Phase III 
clinical trial in Europe  
    * The results of this study should be available during the 
first quarter of 2017 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw4rB2KLa 
Further company coverage:  ASIT.BR   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))